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Neuronal activity disrupts myelinated axon integrity
in the absence of NKCC1b
Katy L.H. Marshall-Phelps1*, Linde Kegel1*, Marion Baraban1, Torben Ruhwedel2, Rafael G. Almeida1, Maria Rubio-Brotons1,
Anna Klingseisen1, Silvia K. Benito-Kwiecinski1, Jason J. Early1, Jenea M. Bin1, Daumante Suminaite1, Matthew R. Livesey1, Wiebke Mo¨bius2,
Richard J. Poole3, and David A. Lyons1
Through a genetic screen in zebrafish, we identified a mutant with disruption to myelin in both the CNS and PNS caused by a
mutation in a previously uncharacterized gene, slc12a2b, predicted to encode a Na+, K+, and Cl− (NKCC) cotransporter, NKCC1b.
slc12a2b/NKCC1b mutants exhibited a severe and progressive pathology in the PNS, characterized by dysmyelination and
swelling of the periaxonal space at the axon–myelin interface. Cell-type–specific loss of slc12a2b/NKCC1b in either neurons or
myelinating Schwann cells recapitulated these pathologies. Given that NKCC1 is critical for ion homeostasis, we asked whether
the disruption to myelinated axons in slc12a2b/NKCC1b mutants is affected by neuronal activity. Strikingly, we found that
blocking neuronal activity completely prevented and could even rescue the pathology in slc12a2b/NKCC1b mutants. Together,
our data indicate that NKCC1b is required to maintain neuronal activity–related solute homeostasis at the axon–myelin
interface, and the integrity of myelinated axons.
Introduction
Interactions between axons and myelinating glia (Schwann cells
in the peripheral nervous system [PNS] and oligodendrocytes in
the central nervous system [CNS]) underpin many aspects of
nervous system formation, health, and function. The myelina-
tion of axons has long been known to facilitate rapid saltatory
conduction due to the multilamellar wrapping of myelin sheaths
around axons and the sequestration of distinct ion channels to
discrete domains along the myelinated axon, including voltage-
gated Na+ channels to nodes of Ranvier. Recently, however, it
has become clear that the physiology of myelinated axons is
more complex than previously thought. For example, it has been
proposed that electrical conduction through the periaxonal
space between the axon and the overlying myelin sheath also
contributes to the fundamental nature of conduction along
myelinated axons (Cohen et al., 2020). Indeed, numerous ion
channels, transporters, and neurotransmitter receptors are
present at the axon–myelin interface and are thus well placed to
regulate myelinated axon physiology, structure, and integrity
(Suminaite et al., 2019). These include axonal ion channels, in-
cluding potassium (K+) channels, that extrude ions into the
periaxonal space upon neuronal activity and channels in the
juxtaposed myelin sheath that buffer ions, including K+, from
the periaxonal space (Rash et al., 2016; Wang et al., 1993;
Schirmer et al., 2018; Larson et al., 2018). In addition, mono-
carboxylate transporters juxtaposed at the axon–myelin inter-
face are thought to mediate the transfer of metabolic substrates
from the myelinating oligodendrocyte to the axon through
the periaxonal space (Saab et al., 2016; Fünfschilling et al.,
2012). Furthermore, receptors for neurotransmitters, neuro-
modulators, and neuropeptides are localized to the axon–
myelin interface (Saab et al., 2016; Micu et al., 2016, 2018) and
have been proposed to mediate adaptations to myelin structure
in response to neuronal activity that may even fine-tune neural
circuit function (Almeida and Lyons, 2017; Monje, 2018; Fields,
2015).
The importance of physiological interactions between axons
and myelinating glia at the axon–myelin interface is only now
becoming clear, with dysregulation implicated in susceptibility
to seizures (Larson et al., 2018), neuronal health (Schirmer et al.,
2018; Saab et al., 2016; Lee et al., 2012; Jha et al., 2020), and
potentially also neurodevelopmental, neuropsychiatric, and
neurodegenerative disorders (Micu et al., 2018; Gibson et al.,
2018; Stassart et al., 2018). To gain deeper insight into myeli-
nated axon biology, we executed a gene discovery screen in
zebrafish, through which we identified a mutant with severe
disruption to myelin. This phenotype was caused by a mutation
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in a previously uncharacterized zebrafish gene, slc12a2b, pre-
dicted to encode a sodium (Na+), potassium (K+), and chloride
(Cl−) cotransporter, NKCC1b. NKCC1 cotransports Na+, K+, and
Cl− together with water, typically from the extracellular space
into cells (Zeuthen and MacAulay, 2012; MacAulay and
Zeuthen, 2010), and has been implicated in regulating many
aspects of ion and fluid homeostasis in the healthy nervous
system (Delpire et al., 1999; Flagella et al., 1999; Dixon et al.,
1999; MacVicar et al., 2002; Su et al., 2002; Larsen et al., 2014;
Stenesen et al., 2019) and following injury and disease (Blaesse
et al., 2009; Ben-Ari, 2017; Yousuf et al., 2017; Gagnon and
Delpire, 2013). Here, we show that NKCC1b is required to
maintain the integrity of myelinated axons following neuronal
activity, implicating it as a key regulator of solute homeostasis
at the axon–myelin interface.
Results and discussion
Mutation of zebrafish slc12a2b disrupts myelination
To help elucidate mechanisms underpinning myelinated axon
formation, health, and function, we performed a mutagenesis-
based gene discovery screen using zebrafish (Kegel et al., 2019;
Klingseisen et al., 2019; see Materials and methods). To assess
myelin, we used the transgenic reporter Tg(mbp:EGFP-CAAX)
in which green fluorescent protein is targeted to the membrane
of myelinating glia (Almeida et al., 2011). One of the mutant
alleles that we identified, ue58, exhibited a striking phenotype,
whereby myelin was disrupted in both the PNS and CNS (Fig. 1
A; Moyon et al., 2019 Preprint). Although CNS pathology was
evident in ue58 mutants, disruption to myelin in the PNS was
more prominent and emerged earlier. We found that myelin
made by Schwann cells along the posterior lateral line nerve
(pLLn) was particularly disrupted (Fig. 1, B and C). In addition,
differential interference contrast (DIC) imaging of ue58mutants
revealed extensive edema (excess fluid) along the entire length
of the pLLn of all mutants (Fig. 1 D). Time-course analyses in-
dicated that myelin appears to form relatively normally by 3 d
postfertilization (dpf) in ue58mutants but become progressively
disrupted from 4 dpf onwards (Fig. S1). Despite the severe de-
rangement of myelin and extensive nerve edema, ue58 homozy-
gous mutants are viable and have no other overt developmental
disruption (Fig. 1 E).
To identify the mutation responsible for the ue58 phenotype,
we performed whole-genome sequencing of mutant larvae
(Materials and methods). This identified genetic linkage be-
tween the mutant phenotype and the start of chromosome 8
(Fig. S2), wherein we identified a T to A base pair change pre-
dicted to induce a stop codon in an ORF partially annotated at the
time of sequence analysis (Fig. 1 F and Fig. S2; Materials and
methods). We identified sequence similarity between this par-
tially annotated region and another zebrafish gene, slc12a2
(Abbas and Whitfield, 2009), which encodes an NKCC1 co-
transporter (Chew et al., 2019), to which we found no linkage of
the mutant phenotype (Fig. S2). To further characterize the
candidate gene on chromosome 8, we amplified mRNA based on
the partially annotated sequence, and identified a product
similar to that encoded by the previously defined slc12a2 gene
(Fig. 1, F–I). Alignment of this new NKCC1-like ORF to genomic
sequence indicated that the ue58 mutation introduced a pre-
mature stop codon in the last exon (exon 26) of the gene
(Fig. 1 F), which is predicted to truncate the last highly con-
served 40 amino acids of the protein (Fig. 1 G).
Quantitative analyses of the myelin phenotype indicated that
only animals homozygous for the ue58 mutation exhibited a
significant disruption to myelination, with heterozygous ani-
mals appearing similar to wild-type animals (Fig. S3, A–D). To
further test whether the ue58mutant phenotype was indeed due
to disruption of this putative NKCC1-encoding gene, we injected
synthetic mRNA encoding our newly isolated NKCC1-like pro-
duct into ue58mutants and found that this rescued their myelin
defects (Fig. S3, E and F). Given the incomplete annotation of the
genome of chromosome 8 at the mutant-linked locus harboring
the NKCC1-like sequence, we independently targeted two re-
gions of the candidate gene using CRISPR guide RNAs. Inde-
pendent targeting of exon 1 or exon 26, where the causative
mutation resided, resulted in severe disruption to myelin mor-
phology, as assessed by Tg(mbp:EGFP-CAAX) (Fig. S4). Together
our data indicate that a novel gene encoding an NKCC1-like
protein is required for the maintenance of myelin and that its
C terminus is functionally essential. Given the previous char-
acterization of a separate NKCC1-encoding gene (slc12a2) in ze-
brafish (Abbas and Whitfield, 2009), we designate our newly
described gene as slc12a2b and the encoded protein as NKCC1b
and suggest that the originally annotated gene be referred to as
slc12a2a and its encoded protein as NKCC1a. The crystal structure
for the zebrafish NKCC1a protein was recently solved and found
similar to that of mouse and human NKCC1 (Chew et al., 2019).
NKCC1a and NKCC1b have the same predicted structure (Fig. 1 H)
and degree of similarity to their mouse and human NKCC1
counterparts (Fig. 1 I), which further indicates that slc12a2b
encodes an NKCC1 cotransporter.
Disruption to NKCC1b leads to enlargement of the periaxonal
space and dysmyelination
Given that NKCC1 typically cotransports ions (Na+, K+, and 2Cl−)
and water into cells, loss of its function would be predicted to
lead to extracellular ion and water accumulation, which could
account for the observed edema and dysregulation of myelin
seen in the slc12a2bue58 mutant. In line with this, glial-specific
disruption to an orthologue of NKCC1 (Ncc69) has been shown to
lead to fluid accumulation in the extracellular space of periph-
eral nerves in Drosophila (Leiserson et al., 2011). We have re-
cently shown, using immunogold labeling of an anti-NKCC1
antibody visualized by EM, that NKCC1 is localized at the
axon–myelin interface in the mammalian CNS, both in the in-
nermost layer of the myelin sheath and the juxtaposed axon
itself (Moyon et al., 2019 Preprint). This positions NKCC1 as a
potential regulator of ion and solute homeostasis at the axon–
myelin interface of vertebrate myelinated axons.
To test how NKCC1b disruption affects peripheral nerve ul-
trastructure, we performed high-pressure freezing–based cry-
opreservation of zebrafish larvae for transmission EM (TEM;
Weil et al., 2019). To increase the likelihood of optimally pre-
serving tissue with edema, we cryopreserved animals between 4
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Figure 1. ue58mutant zebrafish have a severe, peripheral nervemyelin pathology. (A) Confocal images of the spinal cord of Tg(mbp:EGFP-CAAX) control
(left) and ue58mutant (right) at 7 dpf showing disruption to CNS myelin (region within brackets). Scale bar, 10 µm. (B) Confocal images of the pLLn in Tg(mbp:
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and 5 dpf, when the phenotype first emerged. Because we per-
formed our TEM analyses at the onset of pathology, we observed
that many axons were ensheathed by normal appearing myelin,
corroborating our reporter-based time course analyses, which
showed that myelin first appears to be relatively normal before
pathology progresses over time. However, our TEM analyses did
reveal striking edema in the periaxonal space between axons
and overlying multilamellar myelin sheaths in six out of eight
mutant nerves examined (Fig. 2 A). In sufficiently well-preserved
cases, we measured the periaxonal space between the axon and
the first layer of myelin and found that that this was substantially
enlarged in mutant axons (Fig. 2 B). Edema was always found in
association with myelinated axons and never in other regions of
the nerve, including unmyelinated axon bundles, in or near
Schwann cell bodies, or in neighboring tissue. Our observations
support the premise that NKCC1 regulates solute homeostasis at
the axon–myelin interface.
Our TEM analysis also revealed evidence of occasional my-
elin outfoldings (Fig. S5) and a small number of abnormally large
axons (Fig. 2, A and C; and Fig. S5), suggesting the possibility of
additional pathologies in slc12a2b mutants. To investigate this
further, we analyzed transgenic reporters that allowed us to
more broadly assess axonal and myelinating Schwann cell
morphology. To visualize axons in the context of myelination,
we imaged the double transgenic reporter Tg(cntn1b:mCherry,
mbp:EGFP-CAAX) (Fig. 2 D). This showed that axons of the pLLn
were defasciculated and had localized swelling at discrete points
along their length (Fig. 2 D), likely explaining the appearance of
occasional enlarged axons noted by TEM. To assess Schwann cell
morphology, we mosaically labeled cells using a membrane-
tethered reporter (Materials and methods) and observed individ-
ual mutant Schwann cells with variable levels of disruption (Fig. 2
E). While many slc12a2bue58 mutant Schwann cells exhibited signs
of significant swelling, this was accompanied by a shortening of
cell length compared with controls (Fig. 2, E–G). We also observed
that cells could undergo significant membrane blebbing, while
others had myelin outfoldings as indicated by our TEM analysis
(Fig. 2 E and Fig. S5). In some cases, we saw individual Schwann
cells with both areas of normal appearing myelin and grossly
disrupted morphology (Fig. 2 E), indicating the dynamic, pro-
gressive nature of the NKCC1b loss of function pathology.
Together our observations show that disruption to NKCC1b
leads to major dysregulation of the periaxonal space and the
integrity of myelinated axons. It remains to be determined
whether the distinct morphological manifestations of NKCC1b
loss of function all reflect dysregulation of ion and fluid ho-
meostasis at the axon–myelin interface or multiple distinct roles
for NKCC1b in axons and/or myelinating glia.
Loss of NKCC1b function in myelinating glia or neurons
disrupts myelinated axon integrity
To test whether NKCC1b mediates distinct and/or overlapping
roles in myelinating Schwann cells and neurons, we undertook
cell-type–specific approaches using CRISPR-Cas9 technology to
target slc12a2b function. To do so, we placed a gRNA targeting
exon 1 of slc12a2b in a plasmid that also drove expression of the
Cas9 nuclease in a cell-type–specific manner. To drive expres-
sion in myelinating glia, we used the myelin basic protein (mbp)
gene regulatory sequence and for neurons either nefma or nbt
gene regulatory sequences (Fig. 3 A; Materials and methods). We
first saw the dysmyelination and edema characteristic of
slc12a2bue58 mutants in animals in which slc12a2b was specifi-
cally targeted in myelinating glia (Fig. 3, B and C). Reflecting
the mosaic nature of our cell-type–specific targeting, the phe-
notype in animals with myelinating glial loss of slc12a2b func-
tion was observed discontinuously along the nerve. We also
observed disruption to myelin morphology upon neuron-specific
targeting of slc12a2b function (Fig. 3, B and C). Reflecting the
long-range axonal projections of individual neurons of the pos-
terior lateral line ganglion, we saw disruption to myelin along
the entire length of affected nerves in animals with neuron-
specific loss of slc12a2b function.
Together, our results indicate that disruption to NKCC1b in
either myelinating Schwann cells or neurons is sufficient to
drive the pathology seen in constitutivemutants, suggesting that
NKCC1 functions at the axon–myelin interface in both the axon
and Schwann cell to ensure myelinated axon integrity.
Neuronal activity drives the myelin pathology observed in
NKCC1b mutants
The fact that NKCC1 is important for ion homeostasis and that it
is localized to the axon–myelin interface (Moyon et al., 2019
Preprint) suggested the possibility it may have a key role in
regulating ion homeostasis in myelinated axons following neu-
ronal activity. To test this hypothesis, we inhibited neuronal
activity by injecting tetrodotoxin (TTX) into the yolk of 3 dpf
control and constitutive slc12a2bue58 mutant animals to block
action potential firing (Fig. 4 A). We confirmed the efficacy of
EGFP-CAAX) control (top) and ue58mutant (bottom) animals at 5 dpf showing major disruption to myelin. Scale bar, 10 µm. (C) Higher magnification images of
areas demarcated in B showing myelin in control (left) and ue58mutant (right) animals. Scale bar, 10 µm. (D) DIC images of Tg(mbp:EGFP-CAAX) control (left)
and ue58 mutants (right) at 6 dpf showing appearance of tissue edema. Scale bar, 10 µm. (E) Brightfield images of control (left) and ue58 mutants (right) at
6 dpf showing generally normal morphological development. Scale bar, 0.5 mm. (F) Genomic structure of the zebrafish slc12a2b gene, showing exons (boxes)
and introns (lines). White boxes denote untranslated regions. Exons in black were annotated in partial genomic sequences LOC100537771 and LOC100329477
and matched homologous exons in the orthologue slc12a2a. Exons in blue did not align with any annotated genomic sequence, and their limits were inferred by
homology with slc12a2a genomic structure. Exons are drawn to scale relative to each other; introns in pink contain unknown bases (N) and are of unknown size.
The start (ATG) and stop (TGA) codons are indicated in green and red, respectively. The ue58 allele has a T>A mutation in exon 26 leading to a premature stop
codon. (G) Alignment of the 40most C-terminal amino acids of NKCC1b shows high similarity between species in this domain. Arrowhead indicates the position
of the premature stop codon introduced by ue58. (H) Protein structural prediction algorithms, using CCTOP, indicate that NKCC1b in zebrafish is likely to have
intracellular N and C termini and 12 transmembrane domains. (I) Sequence similarities of the protein products of zebrafish NKCC1a, NKCC1b, and murine and
human NKCC1 homologues.
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Figure 2. Disruption to NKCC1b leads to swelling of the periaxonal space, dysmyelination, and axonal disorganization. (A) Electron micrographs of
high-pressure–frozen pLLn in control (left) and slc12a2bue58 mutant (right) at 5 dpf. slc12a2bue58 mutants show significant enlargement of the periaxonal space,
highlighted in blue and enlarged axons (asterisk). Insets show a higher magnification to highlight the periaxonal space in controls and slc12a2bue58 mutants.
White scale bar, 1 µm. Black scale bars, 50 nm. (B)Quantification of periaxonal area in control and slc12a2bue58mutants (control 0.05 ± 0.02 µm2 vs. slc12a2bue58
4 ± 3.5 µm2, P = 0.0065). Error bars represent mean ± SD. A two-tailed Student’s t test was used to assess statistical significance. Each point represents an
individual myelinated axon from three control and five slc12a2bue58 mutant animals. **, P < 0.01. (C) Quantification of the diameter of myelinated axons in
control and slc12a2bue58 mutants. Bracket indicates axons in the mutant with greater than normal diameter. (D) Confocal images of live Tg(cntn1b:mCherry),
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TTX injections by assessing motility and only pursued analyses
of fully paralyzed zebrafish larvae. We found that myelin at
4 dpf was quantitatively indistinguishable between control
animals and TTX-injected slc12a2bue58 mutants, whereas sham-
injected mutants exhibited their characteristic myelin pathology
(Fig. 4, B and C). This indicates that the pathology seen in
animals with loss of NKCC1b function is driven by neuronal
activity. We next asked whether the severe disruption to mye-
linated axons in slc12a2bue58 mutants might be reversible if
neuronal activity was inhibited. We found that TTX injection at
6 dpf, after pathology had emerged, was indeed capable of re-
ducingmyelin disruption in slc12a2bue58mutants (Fig. 4, D, E, and
G), indicating that ongoing neuronal activity contributes to the
progression of pathology. We next wanted to test whether
slc12a2bwas required specifically in myelinating glia to maintain
myelin integrity in response to neuronal activity. We grew
Tg(mbp:EGFP-CAAX) animals in which slc12a2b was disrupted
specifically in myelinating Schwann cells to 6 dpf and screened
them for the presence of myelinated axon pathology. We then
injected a subset of animals exhibiting pathology with either
vehicle or TTX and assessedmyelination (Fig. 4, D and F).While we
continued to see myelin pathology in sham-injected animals with
myelinating glial-specific targeting of slc12a2b, we observed that
pathology was significantly attenuated within hours following TTX
injection (Fig. 4, F and H). This result indicates that NKCC1b is re-
quired by myelinating Schwann cells to maintain solute homeo-
stasis following neuronal activity and myelinated axon integrity.
Our results raise the question as to how neuronal activity can
trigger such a severe pathology in myelinated axons in the ab-
sence of either neuronal or Schwann cell NKCC1b. We predict
that ions released into the periaxonal space upon action poten-
tial firing might not be appropriately buffered without NKCC1b
and that this leads to a cascade of dysregulation that culminates
in the severe pathology observed. Given that K+ ions are released
into the periaxonal space upon action potential firing, failure to
buffer K+ may be a key contributor to the observed pathology,
but how NKCC1b loss of function leads to ion and solute im-
balance causing the observed pathologies (and so rapidly) re-
mains to be investigated. The severe pathology in the slc12a2bue58
mutant PNS also begs the question as to why CNS myelin is less
severely affected. One possibility is that the second NKCC1-
encoding gene in zebrafish, slc12a2a, can compensate for
NKCC1b loss of function in the CNS, but not the PNS. Although we
have not seen disruption to myelin in slc12a2a mutants (data not
shown), the investigation of slc12a2a, slc12a2b double mutants will
be required to test this. There is, however, only one NKCC1-
encoding gene in mammals, and although mutant mice with
conditional knockout of NKCC1 from the oligodendrocyte lineage
show disrupted oligodendrocyte differentiation (Zonouzi et al.,
2015), gross disruption to myelinated axon integrity was not re-
ported. Therefore, an alternative explanation for the more severe
effects of NKCC1b loss in the PNS may be the presence of factors
with redundant functions in the CNS. For example, the inward-
rectifying K+ channel Kir4.1 has been proposed to regulate ion
homeostasis at the axon–myelin interface in the CNS (Larson
et al., 2018; Schirmer et al., 2018), and so it would be interesting
to test whether Kir4.1 and NKCC1 have redundant or distinct roles
in maintaining myelinated axon integrity.
The mechanisms underpinning the complex physiology of
myelinated axons, and in particular functional interactions at
the axon–myelin interface and periaxonal space, remain to be
fully elucidated. At present, there is increasing focus on the
importance of the axon–myelin interface in the CNS, but our
work indicates that this domain is also of key importance to
peripheral nerves. Indeed, Schwann cells express numerous
neurotransmitter receptors (Christensen et al., 2016; Chen et al.,
2017), ion channels, and transporters (Baker, 2002), about
whose functions in vivo we have much to learn. Understanding
the interactions at the axon–myelin interface in both the PNS and
CNS remains an important area of investigation to help fully
elucidate myelinated axon formation, health, and function.
Materials and methods
Zebrafish husbandry and transgenic lines
Adult zebrafish were housed and maintained in accordance with
standard procedures in the Queen’s Medical Research Institute
zebrafish facility, University of Edinburgh. All experiments
were performed in compliance with the UK Home Office, ac-
cording to its regulations under project licenses 60/4035 and 70/
8436. Adult zebrafish were subject to a 14-h/10-h light/dark
cycle. Embryos were produced by pairwisematings and raised at
28.5°C in 10 mM Hepes-buffered E3 embryo medium or condi-
tioned aquarium water with methylene blue. Embryos were
staged according to dpf. The following lines were used in this
study: Tg(mbp:EGFP-CAAX) (Almeida et al., 2011), Tg(cntn1b:
mCherry) (Czopka et al., 2013), and Tg(claudinK:Gal4) (Münzel
et al., 2012). The ue58 allele was identified due to its striking
disruption of mbp:EGFP-CAAX along the pLLn during the for-
ward genetic screen, underpinning this study (described in
Kegel et al., 2019; Klingseisen et al., 2019).
Identification of genetic linkage and causative mutation
Following an outcross to WIK, pooled DNA from 116 ue58mutant
recombinants was sequenced on an Illumina HiSeq4000
Tg(mbp:EGFP-CAAX) double-transgenic control (left) and slc12a2bue58 mutant (right) animals at 5 dpf indicates axonal defasciculation and derangement of
myelin. Scale bar, 10 µm. (E) Confocal images of individual mosaically labeled Schwann cells in control (top left panel) and slc12a2bue58 mutants (panels 1–5)
highlighting the variable morphological manifestation of the mutant phenotype. Scale bar, 10 µm. Arrows point to regions of normal appearing myelin and
arrowheads to dysmyelination. (F) Quantitation of mean Schwann cell diameter in maximum intensity projection images of single Schwann cells at 6 dpf
(control 2.6 ± 0.4 µm vs. slc12a2bue58 4.3 ± 1.3 µm, P = 0.0003). Error bars represent mean ± SD. A two-tailed Student’s t test was used to assess statistical
significance. Each point represents a single cell from 11 control and 10 slc12a2bue58 mutant animals. Scale bar, 10 µm. ***, P < 0.001. (G) Quantitation of mean
Schwann cell length in maximum intensity projection images of single Schwann cells at 6 dpf (control 72.1 ± 15.7 µm vs. slc12a2bue58 54.7 ± 13.8 µm, P = 0.011).
Error bars represent mean ± SD. A two-tailed Student’s t test was used to assess statistical significance. Each point represents a single cell from 11 control and
10 slc12a2bue58 mutant animals. *, P < 0.05.
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(Edinburgh Genomics). We processed this data through a
modified version of the Variant Discovery Mapping CloudMap
pipeline (Minevich et al., 2012) on an in-house Galaxy server
using the Zv9/danRer7 genome and annotation. For both the
Variant Discovery Mapping plots and assessing the list of
candidate variants, we subtracted a list of wild-type variants
compiled from sequencing of the ekwill strain plus previously
published data (Butler et al., 2015; LaFave et al., 2014; Obholzer
et al., 2012).
From the prospective candidate mutations in the region of
chromosome 8 linked to the mutant phenotype, we filtered for
prospective nonsense mutations likely to result in strong loss of
function of encoded proteins. The candidate list was further
filtered by excluding polymorphisms found in other species or
other mutants that we sequenced that derived from the N-ethyl-
N-nitrosourea (ENU)-based screen. We designed genotyping
assays and identified only one candidate stop codon inducing
mutation that was linked to the ue58 mutant phenotype. This
mutation resided in CABZ01084010.1 on chromosome 8 (Zv9)
and was unique in all ue58 sequence reads. From then on, to
genotype ue58 mutant animals, ue58/+ heterozygotes and wild
types, we amplified DNA surrounding the location of the mu-
tation using the following primers: 59-TGATGTTTGTGTTTGTTT
GGTCTCA-39 and 59-CGCTCTGATGGTTTCCTCGG-39.
Figure 3. Cell-type–specific disruption of slc12a2b in either neurons or Schwann cells leads tomyelin pathology. (A) Schematic overviews of constructs
used to induce slc12a2b mutations in myelinating glial cells (top) and neurons (bottom), which are separately injected into embryos at the single-cell stage,
leading to mosaic expression (red dots) at later stages, when myelination is examined. (B) Confocal images of Schwann cells along the pLLn in a 6 dpf Tg(mbp:
EGFP-CAAX) control (top), two genetically mosaic animals in which slc12a2b has been targeted in myelinating glial cells, and two further mosaic animals in
which slc12a2b has been targeted in neurons. Scale bar, 20 µm. (C) Quantitation of mean myelinated nerve diameter in controls compared with larvae with
glial- or neuronal-specific slc12a2b-specific disruption at 6 dpf (control 7.2 ± 1.7 µm vs. glial-specific slc12a2b disruption 10.7 ± 1.8 µm vs. neuronal-specific
slc12a2b disruption 13.6 ± 3.2 µm). Error bars represent mean ± SD. One-way ANOVA followed by Tukey’s multiple comparison test was used to assess
statistical significance (ANOVA F(2,22) = 14.09, P = 0.0001). Each point represents an individual animal. **, P < 0.01; ****, P < 0.0001.
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Figure 4. Neuronal activity drives peripheral nerve pathology in slc12a2b mutants. (A) Schematic overview of when, where and for how long TTX was
applied to slc12a2bue58mutants. (B) Confocal images of a Tg(mbp:EGFP-CAAX) control (top), slc12a2bue58mutant (middle), and slc12a2bue58mutant injected with
TTX (bottom). Scale bar, 20 µm. (C) Quantitation of mean myelinated nerve diameter in controls, slc12a2bue58 mutants and slc12a2bue58 mutants injected with
TTX (control 7.1 ± 0.5 µm vs. slc12a2bue58 13.4 ± 1.9 µm vs. slc12a2bue58+ TTX 6.1 ± 0.9 µm). Error bars represent mean ± SD. One-way ANOVA followed by
Tukey’s multiple comparison test was used to assess statistical significance (ANOVA F(2,27) = 97, P < 0.0001). Each point represents an individual animal. ****,
P < 0.0001. (D) Schematic overview of when, where, and for how long TTX was applied to either constitutive or glial-specific slc12a2b mutants. (E) Confocal
images of 6 dpf slc12a2bue58 mutant larvae. Top and bottom panels show the same region of the pLLn before and 4–6 h after injection with either a control
solution (left), or TTX (right). Scale bar, 20 µm. (F) Confocal images of 6 dpf Tg(mbp:EGFP-CAAX) larvae, in which slc12a2b has been targeted in myelinating glial
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The 145-bp wild-type PCR product is digested with MscI into
43-bp and 102-bp fragments, while mutant sequence remains
uncut. Products were separated on a 2% agarose gel.
Amplification of NKCC1-encoding ORF
Using the Basic Local Alignment Search Tool, we found align-
ment of sequence in the region of our candidate mutation with a
separate, previously identified zebrafish gene, slc12a2, which
encodes the solute transporter NKCC1.
To test whether a gene encoding a NKCC1-like product was
encoded at the mutant-linked locus and to amplify full-length
mRNA that might rescue the ue58 mutant phenotype, we per-
formed PCR with high-fidelity DNA polymerase Q5 (New Eng-
land Biolabs [NEB]) from a pool of wild-type zebrafish total
cDNA (reverse transcribed from total mRNA extracted from AB
5-dpf zebrafish). We used forward primer 59-CATCATGTCAGAC
CAGCCT-39 (bases in bold denote start predicted codon) and
reverse primer 59-CAGGAGTAGAAGGTCAGAAC-39 (bases in
bold denote first two bases of predicted stop codon), which
were designed based on the partial transcript sequences avail-
able for each terminus of a possible slc12a2b gene. This PCR
amplified a cDNA product of ∼3.2 kb, which we purified and
TOPO cloned (using the Zero Blunt TOPO PCR Cloning Kit;
ThermoFisher Scientific) to generate pCRII-slc12a2b. We se-
quenced four pCRII-slc12a2b clones, and in all, we identified a
complete ORF of 3,276 bp. The termini-encoding regions of the
ORF alignedwell with the partial sequences in the database, and
single-nucleotide variations were all annotated in SNPfisher
(Butler et al., 2015) and similar between the clones, suggesting
that these were true SNPs rather than mistakes introduced by
the polymerase during PCR amplification. The slc12a2b cDNA
was then subcloned into the pCS2+ vector for mRNA synthesis
by digesting from pCRII-slc12a2b using EcoRI and ligating into
EcoRI-digested and Alkaline Phosphatase, Calf Intestinal (CIP)-
dephosphorylated pCS2+ vector. The slc12a2b cDNA sequence is
available under NCBI accession no. MK648423.
For slc12a2bue58 mRNA rescue experiments, progeny from
homozygous Tg(mbp:EGFP-CAAX), slc12a2bue58 parents were
injected with 160 pg synthetic slc12a2bue58 mRNA at the one-cell
stage and imaged at 4 dpf for quantification of mean myelinated
nerve diameter compared with Tg(mbp:EGFP-CAAX) wild-type
controls and slc12a2bue58 constitutive mutants.
CRISPR-Cas9–based targeting of slc12a2b
To independently disrupt slc12a2b function, we used a CRISPR
design tool (Integrated DNATechnologies) to identify guide RNA
(gRNA) targeting sequences located in the putative exon 1 and
putative exon 26 of the gene with predicted low off-target ac-
tivity (exon 1, 59-GGGAACCCGAGCCAGGCGG-39; exon 26, 59-
GGTGGACACCGTCCCCTTTC-39). Cas9 protein (1 µg/µl final
concentration; NEB) and gRNA (18 ng/µl final concentration)
were mixed in Cas9 nuclease reaction buffer (20 mM Hepes,
100 mM NaCl, 5 mM MgCl2, and 0.1 mM EDTA, pH 6.5; NEB)
containing 0.05% phenol red and incubated at 37°C for 10 min.
Approximately 2–3 nl active gRNA-Cas9 ribonucleoprotein
complex was injected into Tg(mbp:EGFP-CAAX) embryos at the
one-cell stage and myelin morphology assessed in the days fol-
lowing injection. For each gRNA, at least two independent in-
jection experiments were performed.
To genotype slc12a2bue78 homozygous mutant animals, slc12a2-
bue78/+ heterozygotes and wild types, we amplified DNA sur-
rounding the location of the mutation in exon 1 using the
following primers: 59–GAAGTTCACCACACGGGACC-39 and 59-
GACAATACCGGGCGGTGTCC-39. The 262-bp wild-type PCR pro-
duct is digested with MwoI into 115-bp and 147-bp fragments,
while the mutant sequence remains uncut. Products were sepa-
rated on a 2% agarose gel.
TEM
Control and slc12a2bue58mutant animals were prepared at 4–5 dpf
by high-pressure freezing using a Leica EM ICE apparatus (Leica
Microsystems). As filler, a solution of 20% PVP in E3 embryo
medium was used. Freeze substitution was performed as de-
scribed (Weil et al., 2019). Epon-embedded animals were cut
with a 35° diamond knife (Diatome) using a UC7 ultramicrotome
(Leica Microsystems). Images were obtained with a LEO912
transmission electron microscope (Carl Zeiss Microscopy)
equipped with a 2k on-axis charge-coupled device (CCD) camera
(TRS) between 6,500 and 10,000× with the software iTEM ver-
sion 5.2 (Olympus Soft Imaging Solutions). For overviews at
higher magnification, 4 to 6 images were stitched to a multi-
image assembly by the iTEM software. EM micrographs were
processed using Photoshop Adobe Photoshop CS6 (13.0.1) x64
(Adobe Systems).
Single-cell labeling
Tomosaically label individual Schwann cells, we injected one-cell-
stage Tg(claudinK:Gal4) embryos with a 1 nl solution containing
10 ng/µl pTol2-UAS:EGFP-pA or pTol2-UAS:memScarlet-pA to
label the cytoplasm or membrane of control cells respectively
along with 25 ng/µl tol2 transposase mRNA. To analyze Schwann
cells with disrupted slc12a2b function, we additionally injected
embryos with CRISPR gRNA targeting exon 1 of the slc12a2b gene.
Cell-type–specific targeting of slc12a2b in neurons and
myelinating glial cells
To disrupt slc12a2b function specifically in neurons or myeli-
nating glial cells, we cloned the highly efficient slc12a2b guide
sequence targeting exon 1 into a Tol2modular vector system that
allows coexpression of Cas9 under a tissue-specific promoter
cells. Top and bottom panels show the same region of the pLLn before and 4–6 h after injection with either a control solution (left) or TTX (right). Scale bar, 20
µm. (G) Quantitation of the change in mean myelinated nerve diameter following injection with either a control solution or TTX in slc12a2b mutants (G; sham
injected −0.6 ± 1.1 µm vs. TTX −3.2 ± 1.6 µm, P < 0.0001) or animals in which slc12a2b has been disrupted specifically in myelinating glial cells (H; sham injected
−0.4 ± 1 µm vs. TTX −2.5 ± 1.7 µm, P < 0.0001). Two-tailed Student’s t test was used to assess statistical significance. Each point represents an individual
animal. ****, P < 0.0001.
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(Ablain et al., 2015). Oligonucleotides encoding the 20 bp slc12a2b
exon 1 guide sequence (Integrated DNA Technologies) were li-
gated into the pDestTol2CG2-U6:gRNA destination vector
(Addgene) following BseRI (NEB) restriction digest under the
zebrafish U6-3 promoter. This vector also contains GFP under
the heart-specific cmlc2 promoter as amarker of transgenesis. To
enable neuron or glial-specific slc12a2b loss of function, we then
performed Gateway reactions (Gateway Invitrogen) with 59
entry vectors containing either a 5-kb genomic fragment of ze-
brafish neurofilamentmedium polypeptide a (nefma) regulatory
sequence (see below) or a 6-kb fragment of neural-specific β
tubulin (Kwan et al., 2007) or a 2-kb genomic fragment of ze-
brafish genomic mbp regulatory sequence (Almeida et al., 2011),
with a middle entry vector containing membrane-bound
tagRFPt, followed by the self-cleaving T2A peptide and zebraf-
ish codon-optimized Cas9 sequence flanked by two nuclear lo-
calization signals and 39 entry vector containing a polyA sequence
(Kwan et al., 2007; Fig. 3 A).
One-cell-stage zebrafish embryos were injected with 1 nl of a
solution containing 10 ng/µl plasmid DNA, 25 ng/µl transposase
mRNA, and 0.05% phenol red. Embryos were screened at 3 dpf
for transgene integration as indicated by green heart expression.
Cloning of the nefma regulatory sequence
We amplified 5 kb of sequence immediately upstream of the
nefma gene ORF (NM_001111214.2) from wild-type genomic ze-
brafish DNA using the following primers, which also included
attB1 and attB2R sequences (bold) for cloning purposes: forward
primer, 59-GGGGACAACTTTGTATAGAAAAGTTGCCACCGTAA
TTAACAAATATCCATCAC-39; reverse primer, 59-GGGGACTGC
TTTTTTGTACAAACTTGCGAACTGACGGGGAGTGGAGGTG-39.
The resulting PCR fragment was cloned into the pDONRP4-
P1R plasmid to use as a p5E vector for gateway cloning.
Pharmacological treatments
To inhibit neuronal electrical activity, we injected a 2-nl volume
of 0.5 mM TTX (Tocris Bioscience) into the yolk of zebrafish
larvae. A 3 mM stock of TTX, dissolved in water, was diluted in
10 mM Hepes-buffered E3 embryo medium (pH adjusted 7.4)
containing 0.05% phenol red for injection. Control larvae were
injected with a vehicle solution of E3 embryo medium contain-
ing 0.05% phenol red. For prevention experiments, 3 dpf larvae
homozygous for slc12a2bue58; Tg(mbp:EGFP-CAAX) animals and
Tg(mbp:EGFP-CAAX), as controls, were used. For rescue ex-
periments, either larvae homozygous for slc12a2bue58; Tg(mbp:
EGFP-CAAX) or one-cell-stage Tg(mbp:EGFP-CAAX) embryos
injected with the construct mbp:memtagRFPt2Acas9; U6:
Slc12a2b to enable glial-specific disruption of the gene slc12a2b
were used. Larvae exhibiting signs of myelin pathology were
imaged at 6 dpf and subsequently injected with TTX or a control
solution followed by repeat imaging of the same region of the
posterior later line (around the level of somite 6 for slc12a2bue58
mutants) 4–6 h later. The efficiency of injections was assessed by
complete paralysis of larvae that persisted until the point of
imaging. General health of injected larvae was assessed before
imaging, and any larva showing signs of overt ill health were
excluded from imaging and analysis.
Live imaging and image analysis
For live imaging, zebrafish larvae were anaesthetized in 600 µM
tricaine in embryo medium and mounted in 1.3% or 1.5% low-
melting-point agarose. Live imaging of all transgenic reporters
was performed on a Zeiss 880 LSM confocal microscope equipped
with Airyscan, typically in superresolution mode, using a 20×
objective lens (Zeiss Plan-Apochromat 20× dry, NA = 0.8). An
Olympus microscope capable of DIC imaging was used to image
tissue edema in slc12a2bue58 mutants using 60× water-immersion,
NA = 1 objective lens. A Nomarski prism and polarizer were ori-
ented in such a way as to provide DIC. All images depict a lateral
view of the spinal cord with anterior to the left and dorsal to the
top. Figure panels were prepared using Fiji and Adobe Illustrator
CC version 24.1.1 (Adobe Systems).
To quantify myelin morphology from images of live Tg(mbp:
EGFP-CAAX) animals, we performed automatic thresholding of
maximum intensity projections, via the Huang method using
ImageJ/Fiji (Schindelin et al., 2012, 2015). The thresholded im-
ages were then converted to masks and inverted, and objects
were detected using ImageJ’s Analyze Particles function. Iden-
tified particles were then assessed for area (µm2) and relative
fluorescence intensity (mean gray value), and total fluorescence
was calculated as the sum of (mean gray value × particle area)
for all relevant particles in any given image. The total visible
myelinated nerve length was calculated (by summing all x co-
ordinates uniquely occupied by particles) and used to calculate
either the mean myelinated nerve or Schwann cell diameter
(total area/visible myelinated nerve length).
Statistical analysis
Statistical tests were performed using GraphPad Prism (version
8). Data were tested for normal distribution using D’Agostino–
Pearson omnibus test and tested for significance by two-tailed
Student’s t test or one-way ANOVA with Tukey’s multiple com-
parisons test where applicable. All data are expressed as mean ±
SD. All data points represent individual animals unless otherwise
specified as indicated in the figure legends, with symbols indi-
cating the following P value ranges: *, P < 0.05; **, P < 0.01; ***, P <
0.001; ****, P < 0.0001.
Online supplemental material
Fig. S1 shows that myelin in ue58 mutants forms normally but
becomes progressively disrupted. Fig. S2 shows a molecular
characterization of the ue58mutation and slc12a2b. Fig. S3 shows
that slc12a2b disruption leads to myelin pathology. Fig. S4 shows
validation of slc12a2b loss of function in CRISPR/Cas9 mutant
animals. Fig. S5 shows periaxonal space swelling, axonal enlarge-
ment, and myelin outfoldings in slc12a2bue58 mutants.
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Supplemental material
Figure S1. Myelin in ue58mutants forms normally but becomes progressively disrupted. (A) Confocal images of the pLLn in Tg(mbp:EGFP-CAAX) control
heterozygote (left) and ue58 homozygote mutant (right) animals at 3, 4, and 7 dpf. Scale bar, 10 µm.
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Figure S2. Molecular characterization of the ue58 mutation and slc12a2b. (A) Variant discovery mapping plots from the CloudMap pipeline showing the
normalized frequency of pure homozygous variants (allele frequency in recombinant pool = 1.0) in 2.5-Mb (green) or 5-Mb (gray) bins. Note linkage at the
beginning of chromosome 8, but none in 10, as a comparison, and where slc12a2a is localized. (B) Raw sequence reads in the candidate region defined by
mapping shows a T to A change in the ue58 mutant reads, but not in an unrelated mutant, ue57.
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Figure S3. Disruption to slc12a2b leads to myelin pathology. (A) Images of the pLLn in Tg(mbp:EGFP-CAAX) wild-type, slc12a2b ue58/+ and slc12a2bmutant
animals at 5 dpf. Scale bar, 10 µm. (B) Quantitation of mean myelinated nerve diameter in wild-type, slc12a2b ue58/+ and slc12a2bmutant animals at 5 dpf (wild
type 7.2 ± 0.7 µm vs. slc12a2b ue58/+ 7.2 ± 1 µm vs. slc12a2b ue58 10.8 ± 1.4 µm). Error bars represent mean ± SD. One-way ANOVA followed by Tukey’s multiple
comparison test was used to assess statistical significance (ANOVA F(2,19) = 23.9, P < 0.0001). Each point represents an individual animal. ****, P < 0.0001.
(C) Images of Tg(mbp:EGFP-CAAX) wild-type, slc12a2b ue58/+, and slc12a2b mutant animals at 7 dpf. Scale bar, 10 µm. (D) Quantitation of mean myelinated
nerve diameter in wild-type, slc12a2b ue58/+ and slc12a2bmutant animals at 7 dpf (wild type 7.9 ± 0.6 µm vs. slc12a2b ue58/+ 7.4 ± 0.6 µm vs. slc12a2b ue58 13.2 ±
2.6 µm). Error bars represent mean ± SD. One-way ANOVA followed by Tukey’s multiple comparison test was used to assess statistical significance (ANOVA
F(2,26) = 44.1, P < 0.0001). Each point represents an individual animal. ****, P < 0.0001. (E) Images of Tg(mbp:EGFP-CAAX) wild-type, control-injected slc12a2b
mutant, and slc12a2b mRNA–injected mutant animals at 4 dpf. Scale bar, 10 µm. (F) Quantitation of mean myelinated nerve diameter in wild-type, control-
injected slc12a2bmutant, and slc12a2bmRNA–injected mutant animals at 4 dpf (wild type 6.7 ± 0.5 µm vs. slc12a2b ue58 11.2 ± 1 µm vs. slc12a2bue58 +mRNA 5.2 ±
0.6 µm). Error bars represent mean ± SD. One-way ANOVA followed by Tukey’s multiple comparison test was used to assess statistical significance (ANOVA
F(2,17) = 1.2, P < 0.0001). Each point represents an individual animal. *, P < 0.05; ****, P < 0.0001.
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Figure S4. Validation of slc12a2b loss of function in CRISPR/Cas9 mutant animals. (A) Images of the pLLn in Tg(mbp:EGFP-CAAX) wild-type (top),
slc12a2bmutant animals (second panel) and Tg(mbp:EGFP-CAAX) wild-type animals injected with CRISPR guide RNAs targeting exon 1 of slc12a2b (third panel)
and exon 26 (bottom panel) of slc12a2b. Scale bar, 20 µm. (B) Genomic structure of the zebrafish slc12a2b gene, as in Fig. 1, showing the CRISPR guide RNA
targeting sequence located within exon 1 (orange). Sanger sequencing from second generation slc12a2bue78 mutants reveals a 5 bp deletion upstream of the
PAM cleavage site within exon 1 of the slc12a2b gene. Deletion of this sequence disrupts the MwoI restriction enzyme recognition site, allowing mutant animals
to be genotyped based on the presence of undigested product. (C) Sanger sequence chromatograms of slc12a2bue78 mutants compared with wild-type controls
showing region of 5 bp deletion (arrows). (D) Alignment of predicted amino acid sequences in slc12a2bue78 mutants and wild-type controls. The 5 bp deletion in
mutants produces a frameshift in the coding sequence (arrow) and introduction of a premature translational stop codon (asterisk). (E) Confocal images of 5 dpf
Tg(mbp:EGFP-CAAX) wild-type (top) and second-generation slc12a2bue78 mutant animals (bottom) showing major myelin disruption along the pLLn. Scale bar,
20 µm.
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Figure S5. Periaxonal space swelling, axonal enlargement, and myelin outfoldings in slc12a2bue58 mutants. (A) TEM images of the pLLn in control (left)
and slc12a2bue58 mutant animals showing an enlarged axon (asterisk) with periaxonal swelling (middle) and myelin outfoldings (arrowheads; right). Scale bar,
1 µm.
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